Search Results

Displaying Results 1551-1575 of 6949 "'J'"

Mar 27, 2026, 09:00 ET UCB Presents New BIMZELX® (bimekizumab-bkzx) Data at AAD Demonstrating High Rates of Durable and Complete Skin Clearance in Moderate-to-Severe Plaque Psoriasis

2021;397(10273):487–98.4. Reich K, Warren RB, Lebwohl M, et al. Bimekizumab versus Secukinumab in Plaque Psoriasis. N Engl J Med. 2021;385(2):142–52.5. Armstrong AW, Schupp C, Wu J, et al. Quality of Life and Work Productivity Impairment among Psoriasis Patients: Findings from the National Psoriasis

More news about: UCB


Mar 27, 2026, 09:00 ET The future of skin aging may be found in the kitchen: 2026 American Academy of Dermatology Annual Meeting to highlight latest advancements in skin, hair, and nails

Lawrence J. Green, MD, FAAD, a board-certified dermatologist and Clinical Professor of Dermatology at George Washington University School of Medicine, in Washington,

More news about: American Academy of Dermatology


Mar 27, 2026, 09:00 ET UCB Announces New BIMZELX® (bimekizumab-bkzx) Data at AAD Showing Durable Symptom Control Throughout Three Years in Hidradenitis Suppurativa

Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment. Br J Dermatol. 2014;171(6):1434–42.Jemec GBE. Clinical practice. Hidradenitis suppurativa. N Engl J Med. 2012;366(2):158–64.Kimball AB, Jemec GBE, Sayed CJ, et al. Efficacy and safety

More news about: UCB


Mar 27, 2026, 09:00 ET TENEO EXPANDS GLOBAL POLITICAL RISK ADVISORY BUSINESS

and component levels and previously served as Director of the Chairman's New Administration Transition Team, Director of Strategic Plans and Policy (J-5) for the Joint Staff, and Director of the Joint Staff.General James Hecker, USAF (Ret.) served as Commander

More news about: Teneo


Mar 27, 2026, 08:38 ET BionicM and Brooks Rehabilitation Launch Clinical Study Comparing Powered Bio Leg to Microprocessor Knees

individuals with transfemoral amputation who utilize prosthetic knee technology in daily life.The research is led by Principal Investigator Emily J. Fox, PhD, DPT, MHS, director of neuromuscular research at Brooks Rehabilitation and the Brooks Motion Analysis Center, with clinical leadership and

More news about: BionicM LLC USA


Mar 27, 2026, 08:33 ET Is This a Real Sitcom? Comedian Concrete Leaves Fans Guessing With "Chair-Man of The Board"

nationwide. He later spent more than a decade directing and shooting videos for major artists including Baby Bash, Chiquis, C-Kan, Damian Marley, Frankie J, MC Magic, and Peso Pluma. His visual work has surpassed 500 million views across platforms.Concrete has also built an acting career with

More news about: Concrete


Mar 27, 2026, 08:00 ET Geneva Trust Company reclama en Puerto Rico $50 millones en activos en el caso Bancrédito

indulto pleno e incondicional del presidente Donald J. Trump. Fuentes de la Casa Blanca señalaron que dicha investigación constituía un ejemplo de

More news about: MP Publishing


Mar 27, 2026, 08:00 ET Geneva Trust Company Pursues $50 Million in Assets in Puerto Rico Bancrédito Case

full and unconditional pardon from President Donald J. Trump. White House sources indicated that the investigation constituted an example of

More news about: MP Publishing


Mar 27, 2026, 08:00 ET Geneva Trust Company reclama en Puerto Rico $50 millones en activos en el caso Bancrédito

indulto pleno e incondicional del presidente Donald J. Trump. Fuentes de la Casa Blanca señalaron que dicha investigación constituía un ejemplo de

More news about: MP Publishing


Mar 27, 2026, 07:52 ET Zeto Announces 2026 Clinical Trial Sponsorship Winners Advancing EEG in Stroke, Delirium, and Epilepsy

quantify.Optimization of Neuromodulation Therapy for Drug-Resistant Epilepsy Using Short-Term Evoked Response Signatures, by Dr. Jonathon J. Parker (Mayo Clinic Arizona, USA)This project will investigate how short-term EEG biomarkers can guide personalized neuromodulation therapy.

More news about: Zeto, Inc.


Mar 27, 2026, 07:30 ET Keenova Presents a New TERLIVAZ® (terlipressin) Clinical Analysis at the SHM Converge

with Terlipressin: A Retrospective Cohort StudyAuthors: A. Sidney Barritt IV, MD; Kavish R. Patidar, DO; Robert J. Wong, MD, MS; Xingyue Huang, PhD; Rachel Black, PharmD; Mary Panaccio, PhD; Jonathan Lilley, BA; Nisha Wadhwani, PhD; Rahul Rajkumar, MD, MPH; Christopher

More news about: Keenova Therapeutics


Mar 27, 2026, 07:10 ET OceanaGold Files Annual Information Form and Updated Technical Reports for Haile, Macraes and Didipio

of December 31, 2025, prepared by D. Carr, Group Head of Metallurgy, G. Hollett, Group Head of Mining Engineering, B. Drury, Underground Engineering Superintendent, J. Moore, Group Head of Resource Development, D. Corley, Principal Resource Development Geologist, L. Standridge (Call & Nicholas Principal Engineer,

More news about: OceanaGold Corporation


Mar 27, 2026, 06:45 ET Neutrogena®, Aveeno® and Rogaine® Release New Dermatology Research and Clinical Skincare Innovations on Healthy Aging, Moisturization, Sun Protection and Acne

Tolerance. Presented at: American Academy of Dermatology Annual Meeting; March 27-31, 2026; Denver, Colorado.ix Luts T, DeVoe C, Williams J. Formulating high efficacy sunscreens with bis-ethylhexyloxyphenol methoxyphenyl triazine (BEMT): a new sunscreen filter expected to be approved in the

More news about: Kenvue Inc.


Mar 26, 2026, 23:56 ET Southeast Asia Color Cosmetics Market to Reach USD 6.98 Billion by 2032, Growing at a CAGR of 7.08%, Says MarkNtel Advisors

strong adoption, particularly among younger demographics.Furthermore, increasing exposure to global beauty trends, especially K-beauty and J-beauty, is encouraging consumers to experiment with diverse product formats, textures, and finishes. As a result, demand is rising for cosmetics offering

More news about: MarkNtel Advisors


Mar 26, 2026, 19:52 ET FDA approves Novo Nordisk's Awiqli®, the first and only once-weekly basal insulin treatment for adults with type 2 diabetes

https://doi.org/10.2337/dc26-S005Rosenstock J, Gowda A, Liang B. Weekly icodec versus daily glargine U100 in type 2 diabetes without previous insulin. N Engl J Med. 2023 2023;389(16):1533. doi:10.1056/NEJMc2310221Philis-Tsimikas A, Asong M, Franek

More news about: Novo Nordisk


Mar 26, 2026, 16:05 ET CROWN HOLDINGS, INC. APPOINTS DR. JOHN M. ROST EXECUTIVE VICE PRESIDENT AND CHIEF OPERATING OFFICER - ASIA PACIFIC AND TRANSIT PACKAGING

responsible for Asia Pacific and will also add responsibility for the Company's global Transit Packaging operations.  He will continue to report to Timothy J. Donahue, Chairman, President and Chief Executive Officer. Prior to his current role, Dr. Rost held the position of Senior Vice President – Technology,

More news about: Crown Holdings, Inc.


Mar 26, 2026, 15:03 ET AcreConnect® Integrates with EAVision Drones

structure reduces errors and eliminates the risk of misplaced or incomplete flight logs."Any current EAVision drone, and future models such as the J70, can take advantage of this integration," said Jeff Holman, Chief Product and Technology Officer (CPTO) at American Autonomy, Inc. "API integrations

More news about: AcreConnect


Mar 26, 2026, 14:40 ET Greenberg Traurig's Real Estate Practice Adds Hospitality Lawyer Mitch Reynolds to Singapore Team

Elias J. Hayek, co-chair of the firm's Middle East and European Hospitality Group. "Mitch brings a sophisticated understanding of hospitality transactions

More news about: Greenberg Traurig, LLP


Mar 26, 2026, 14:00 ET Disrupting AI: Why We Should Stop Teaching Writing and Start Teaching Logic, with Alan Paulin

power of Anti-PR to drive markets and impact market perception.ReferencesBick, A., Blandin, A., & Deming, D. J. (2024). The rapid adoption of generative AI (NBER Working Paper No. 32966; rev. February 2025). National Bureau of Economic Research. Doi.org/10.3386/w32966Brynjolfsson,

More news about: Disruption Interruption


Mar 26, 2026, 13:10 ET Norgine annuncia l'approvazione da parte di Swissmedic di PEDMARQSI® per la prevenzione della perdita dell'udito indotta da cisplatino nei bambini

https://www.ema.europa.eu/en/medicines/human/EPAR/pedmarqsi#product-info. Consultato nel marzo 2026Brock PR, et al. N Engl J Med 2018; 378(25): 2376–2385Freyer DR, et al. Lancet Oncol 2017; 18(1): 63–74EMA. PEDMARQSI. Disponibile all'indirizzo:

More news about: Norgine


Mar 26, 2026, 13:00 ET Pinnacle Mergers & Acquisitions Facilitates Sale of Lexus of Warwick in Rhode Island

McGee and his team - a smooth transaction throughout.""This was an extremely smooth transaction with two outstanding teams," said Dennis J. Thornhill, Executive Advisor at Pinnacle Mergers & Acquisitions. "The McGee family has a long history of being a tremendous ambassador of the

More news about: Pinnacle Mergers and Acquisitions


Mar 26, 2026, 12:46 ET Norgine anuncia la aprobación por parte de Swissmedic de PEDMARQSI®

https://www.ema.europa.eu/en/medicines/human/EPAR/pedmarqsi#product-info. Consultado en marzo de 2026Brock PR, et al. N Engl J Med 2018; 378(25): 2376–2385Freyer DR, et al. Lancet Oncol 2017; 18(1): 63–74EMA. PEDMARQSI. Disponible en:

More news about: Norgine


Mar 26, 2026, 12:40 ET Gradient Toxicologist Dr. Cassandra J. Meakin Receives Society of Toxicology Award

Gradient Toxicologist Dr. Cassandra J. Meakin has received the Early Career Achievement Award from the Medical Device and Combination Products Specialty Section of the Society of Toxicology.BOSTON, March 26, 2026

More news about: Gradient LLC


Mar 26, 2026, 11:00 ET JW MARRIOTT TUCSON STARR PASS RESORT & SPA REVEALS REIMAGINED MEETING EXPERIENCES IN THE HEART OF THE REAL ARIZONA

consists of beautiful properties and distinctive resort locations around the world. JW Marriott is a tribute to the founder of Marriott International, J. Willard "J.W." Marriott, who prioritized his own well-being so that he could take better care of others. Inspired by his approach to life and rooted

More news about: JW Marriott Tucson Starr Pass Resort & Spa


Mar 26, 2026, 10:00 ET Labaton Keller Sucharow LLP Announces Notice of Pendency of Class Action, Proposed Settlement, and Motion for Attorneys' Fees and Expenses in In re PG&E Corporation Securities Litigation

Nos. 19-30088 and 19-30089 (Bankr. N.D. Cal.), in the amount of $100,000,000.A final Settlement Hearing will be held before the Honorable Edward J. Davila on August 25, 2026, at 9:00 a.m., either in person or remotely, at the District Court's discretion, in Courtroom 4 of the Robert F. Peckham Federal

More news about: Labaton Keller Sucharow LLP


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.